Who qualifies for Orforglipron?
Orforglipron · orforglipron · by Eli Lilly
Reviewed by the WeighedHealth Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of July 2026; updated when guidance or availability changes.
Adults with obesity (BMI ≥30, or ≥27 with comorbidity) or type 2 diabetes, per the launch indications. Especially relevant for needle-averse patients who declined injectable GLP-1s. Same thyroid C-cell contraindication class as other GLP-1s.
More on Orforglipron
- How much does Orforglipron cost?
- Orforglipron side effects
- Orforglipron dosing and titration schedule
- How does Orforglipron work?
- Orforglipron drug interactions
- Orforglipron and pregnancy: safety, planning, breastfeeding
- Orforglipron and alcohol: what to know
- Orforglipron missed dose: what to do
- Orforglipron savings: coupons, manufacturer programs, lower-cost options
- ← Full Orforglipron overview
Frequently asked
Am I eligible for Orforglipron?+
Adults with obesity (BMI ≥30, or ≥27 with comorbidity) or type 2 diabetes, per the launch indications. Especially relevant for needle-averse patients who declined injectable GLP-1s. Same thyroid C-cell contraindication class as other GLP-1s.
Who should not take Orforglipron?+
Anyone with the documented contraindications listed above. Always disclose full medical history, current medications, and family cancer history to the prescribing clinician.